Lei Yu, PhD; Lori B. Chibnik, PhD; Gyan P. Srivastava, PhD; et al.
free access
JAMA Neurol. 2015;72(1):15-24. doi:10.1001/jamaneurol.2014.3049
Ongoing community-based clinical pathological cohort studies of aging and dementia demonstrate that brain DNA methylation in multiple AD loci is associated with AD pathologies.
-
Editorial
Exploring the Epigenetics of Alzheimer Disease
Bryan J. Traynor, MD, PhD; Alan E. Renton, PhD
JAMA Neurol
Martin Ebinger, MD; Alexander Kunz, MD; Matthias Wendt, MD; et al.
free access
JAMA Neurol. 2015;72(1):25-30. doi:10.1001/jamaneurol.2014.3188
A substudy of the prospective controlled Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke study indicates that golden hour thrombolysis increases with the deployment of a stroke emergency mobile unit.
Ann M. Arvin, MD; Jerry S. Wolinsky, MD; Ludwig Kappos, MD, PhD; et al.
free access
has audio
JAMA Neurol. 2015;72(1):31-39. doi:10.1001/jamaneurol.2014.3065
This analysis of pooled data from 6 completed phase 2 and 3 studies of fingolimod and ongoing extension studies recommends that varicella-zoster virus immune status be established in patients receiving fingolimod therapy for multiple sclerosis (MS).
-
Podcast:
Varicella-Zoster Virus Infections in MS (JAMA Neurology)
Feng-Cheng Lin, MD; Ching-Piao Tsai, MD; Johnny Kuang-Wu Lee, PhD; et al.
free access
JAMA Neurol. 2015;72(1):40-48. doi:10.1001/jamaneurol.2014.3367
This total population–based case-control study found that the use of angiotensin-converting enzyme inhibitors showed a dose-dependent inverse association with amyotrophic lateral sclerosis.
Nimeshan Geevasinga, MBBS; Parvathi Menon, MBBS; James Howells, PhD; et al.
free access
JAMA Neurol. 2015;72(1):49-57. doi:10.1001/jamaneurol.2014.2940
This prospective study found that upregulation of persistent Na+ conductances and reduced K+ currents were evident in both c9orf72 familial amyotrophic lateral sclerosis and sporadic amyotrophic lateral sclerosis cohorts.
Ilir Agalliu, MD, ScD; Marta San Luciano, MD; Anat Mirelman, MD; et al.
free access
JAMA Neurol. 2015;72(1):58-65. doi:10.1001/jamaneurol.2014.1973
This multinational study demonstrates that LRRK2 G2019S mutation carriers have an overall increased risk of cancer, especially for hormone-related cancer and breast cancer in women.
Jeffrey M. Gelfand, MD, MAS; Gillian Genrich, MD, MPH; Ari J. Green, MD, MAS; et al.
free access
JAMA Neurol. 2015;72(1):66-72. doi:10.1001/jamaneurol.2014.2376
This retrospective case series recommends that subsequent review of biopsy materials, ancillary testing, clinical correlation, and clinical follow-up be performed in patients with encephalitis, not otherwise specified.
Enyinna L. Nwachuku, BS; Jeffrey R. Balzer, PhD; Jonathan G. Yabes, PhD; et al.
free access
JAMA Neurol. 2015;72(1):73-80. doi:10.1001/jamaneurol.2014.3071
This systematic review and meta-analysis reports that intraoperative somatosensory-evoked potential is a highly specific test in predicting neurological outcome following carotid endarterectomy. Patients with perioperative neurological deficits are 14 times more likely to have had changes in somatosensory-evoked potentials during the procedure. The use of somatosensory-evoked potentials to design prevention strategies is valuable in reducing perioperative cerebral infarctions during carotid endarterectomy.
Eoin P. Flanagan, MBBCh; Brian G. Weinshenker, MD; Karl N. Krecke, MD; et al.
free access
JAMA Neurol. 2015;72(1):81-87. doi:10.1001/jamaneurol.2014.2137
This original investigation reports that short transverse myelitis is not uncommon in neuromyelitis optica spectrum disorders and, when it is present, delays diagnosis/treatment. Clinical and radiological characteristics identified in this study may help select patients with short transverse myelitis who are at the highest risk for a neuromyelitis optica spectrum disorder. Short transverse myelitis does not exclude consideration of aquaporin-4-IgG testing or neuromyelitis optica spectrum disorder diagnosis.
Kara M. Smith, MD; Eli Eyal, MSc; Daniel Weintraub, MD; et al.
free access
JAMA Neurol. 2015;72(1):88-95. doi:10.1001/jamaneurol.2014.2472
This exploratory post hoc analysis found that the combination of rasagiline and antidepressants in patients with Parkinson disease is associated with reduced worsening of a range of nonmotor symptoms.